Are you unsure whether Cipla Actin is actually the best option for your weight-gain requirements? It’s a worthwhile question to investigate. Losing weight can be difficult for some people, but ...

Umang Vohra to Nimura: "In the case of tariff barriers, generics companies are likely to be more selective, focusing on high-value opportunities including 'first to file'." The Managing Director ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Cipla has entered a phase of sideways consolidation after a decline of approximately 19.7 per cent from its all-time high, with support at Rs 1,366 and resistance at Rs 1,502. A decisive break and ...

Spir proteins nucleate actin polymerization by assembling a linear actin oligomer along a cluster of four actin-binding WH2 domains, and this process is enhanced by formins of the Cappuccino family.

IPO Watch: Allchem Lifescience Limited has filed its draft red herring prospectus (DRHP) with the capital market regulator, Securities and Exchange Board of India (SEBI), for an initial public ...

The department has launched an inquiry in the matter and said that appropriate actin will be taken for all involved in the matter. Earlier, Elon Musk-led Department of Government Efficiency (DOGE ...

IndusInd Bank’s revelation of a 2.35 per cent decline in net worth due to discrepancies in its derivative trades has brought to the fore concerns about the risks inherent in the banking sector.

Cipla has recently fallen below its 20-day Exponential Moving Average, currently standing at a price of Rs 1460.3. Today, it has experienced a change of -1.11%, with the 20-day EMA noted at 1460.34.

Cipla's stock is priced at Rs 1455.95, showing a percentage change of 0.71% today, alongside 1-day returns of 0.19%. Cipla is currently valued at Rs 1449.5, experiencing a minor rise of 0.26% today, ...